Clinical Trials in Houston

Showing 2621-2640 of 8,625 trials

Venous Ethanol for Ventricular Tachycardia

NCT05511246

Comparative effectiveness randomized clinical trial, comparing endocardial radiofrequency ablation alone vs radiofrequency ablation combined with venous ethanol in patients with ischemic ventricular tachycardia -Venous Ethanol for Left Ventricular Ischemic Ventricular Tachycardia -VELVET clinical trial

Ventricular TachycardiaIschemic Cardiomyopathy

The Methodist Hospital Research Institute156 participantsStarted Apr 2023

Houston, Texas, United States

RECRUITINGNA< 1 mile

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

NCT05204888

Parallel-group, prospective, randomized, controlled phase III trial of home High flow Nasal Therapy (HFNT) via myAirvo 3 plus usual COPD medical care vs. usual COPD medical care, for at least 1 year and up to two years in 642 GOLD Grade D, Stages II-IV patients with moderate to very severe COPD at risk for moderate and severe exacerbations with a prior history of severe exacerbation requiring hospitalization within the past 6 weeks.

COPD

Temple University642 participantsStarted Feb 2022

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Jacksonville, Florida, United States +24 more locations

Venous Ethanol for Ventricular Tachycardia

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Find Trials by Condition in Houston

Continuous Diffusion of Oxygen Treatment for Incision Wounds

Study of Magrolimab in Combination With Azacitidine Versus Physician's Choice of Venetoclax in Combination With Azacitidine or Intensive Chemotherapy in Patients With TP53 Mutant Acute Myeloid Leukemia That Have Not Been Treated

Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)

Combination Study of SV-BR-1-GM With Retifanlimab

A Phase 2b Study of BNC210 Tablet Formulation in Adults With Post-Traumatic Stress Disorder (PTSD)

Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis

Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients

A Study of Ad26.COV2.S in Adults (COVID-19)

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease

Real-World Study of Enzalutamide and Abiraterone Acetate (With Prednisone) Tolerability

Different Doses of Naronapride Vs. Placebo in Gastroparesis

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)

A Study of Different Combination Regimens Including JNJ-73763989 and/or JNJ-56136379 for the Treatment of Chronic Hepatitis B Virus Infection

Safety and Immunogenicity of CodaVax-RSV in Seropositive and Seronegative Children

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancer